Exosome Diagnostics, Inc., the developer of a revolutionary liquid biopsy platform that enables non-invasive diagnosis of serious diseases, aiming to reduce or eliminate the need for tissue biopsies, ...
DUBLIN--(BUSINESS WIRE)--The "Exosome Diagnostics, Therapeutics and Research Tools: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for exosome ...
August 24, 2017 - Baltimore, Md. and Boston, Ma., Aug. 24, 2017 (GLOBE NEWSWIRE) -- CareFirst BlueCross BlueShield (CareFirst) and Exosome Diagnostics, Inc. (ExoDx) announced today that they have ...
DUBLIN--(BUSINESS WIRE)--The "Global Exosome Market: Size, Forecast, Trials, and Trends, 2024" report has been added to ResearchAndMarkets.com's offering. Exosomes are extracellular vesicles (EVs) ...
MINNEAPOLIS, Aug. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoDx ...
Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has reported results from a proof-of-concept study for a novel exosome-based platform that could ...
The exosome diagnostic and therapeutic market was valued at US$ 41.6.33 million in 2019 and is expected to grow at a CAGR of 32.2% from 2020 to 2027 to reach US$ 358.91 million 2027. According to The ...
NEW YORK, June 30, 2023 /PRNewswire/ -- The exosome diagnostics and therapeutics market size is set to grow by USD 483.18 million from 2022 to 2027 and register an accelerating CAGR of 21.55%, ...
(MENAFN- EIN Presswire) EINPresswire/ -- Overview of the Market: The Exosome Diagnostics and Therapeutics Market is emerging as one of the fastest-developing sectors within precision medicine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results